Literature DB >> 8919337

Epidemiology of inflammatory bowel disease in different ethnic and religious groups: limitations and aetiological clues.

C S Probert1, V Jayanthi, D S Rampton, J F Mayberry.   

Abstract

We present a review of epidemiological studies of inflammatory bowel disease and abdominal tuberculosis in various migrant communities in the United Kingdom. The differences between various South Asian groups such as Gujaratis, Bangladeshis and Punjabis are discussed in the context of age standardisation of incidence data and various dietary and social activities.

Entities:  

Mesh:

Year:  1996        PMID: 8919337     DOI: 10.1007/bf00418851

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  19 in total

1.  Low incidence of ulcerative colitis and proctitis in Bangladeshi migrants in Britain.

Authors:  V Jayanthi; C S Probert; D J Pollock; S I Baithun; D S Rampton; J F Mayberry
Journal:  Digestion       Date:  1992       Impact factor: 3.216

2.  The distribution of ulcerative colitis and regional enteritis in United States veterans with particular reference to the Jewish religion.

Authors:  E D ACHESON
Journal:  Gut       Date:  1960-12       Impact factor: 23.059

3.  Epidemiology of Crohn's disease in Indian migrants and the indigenous population in Leicestershire.

Authors:  V Jayanthi; C S Probert; D Pinder; A C Wicks; J F Mayberry
Journal:  Q J Med       Date:  1992-02

Review 4.  Smoking and prevention.

Authors:  V Jayanthi; C S Probert; K S Sher; J F Mayberry
Journal:  Respir Med       Date:  1991-05       Impact factor: 3.415

5.  Stoma anxieties: a comparison of the attitudes of Asian migrants and the indigenous population in the United Kingdom towards abdominal surgery and the role of intestinal stomas.

Authors:  P Bhakta; C S Probert; V Jayanthi; J F Mayberry
Journal:  Int J Colorectal Dis       Date:  1992-02       Impact factor: 2.571

6.  Crohn's disease in West Indians.

Authors:  I W Fellows; J F Mayberry; G K Holmes
Journal:  Am J Gastroenterol       Date:  1988-07       Impact factor: 10.864

7.  Ulcerative colitis in the Jewish population of Tel-Aviv Jafo. I. Epidemiology.

Authors:  T Gilat; J Ribak; Y Benaroya; Z Zemishlany; I Weissman
Journal:  Gastroenterology       Date:  1974-03       Impact factor: 22.682

8.  Crohn's disease in the city of Derby, 1951-85.

Authors:  I W Fellows; J G Freeman; G K Holmes
Journal:  Gut       Date:  1990-11       Impact factor: 23.059

9.  Incidence of abdominal tuberculosis in Bangladeshi migrants in east London.

Authors:  C D Sheldon; C S Probert; H Cock; K King; D S Rampton; N C Barnes; J F Mayberry
Journal:  Tuber Lung Dis       Date:  1993-02

10.  Crohn's disease in Jewish people--an epidemiological study in south-east Wales.

Authors:  J F Mayberry; D Judd; H Smart; J Rhodes; B Calcraft; J S Morris
Journal:  Digestion       Date:  1986       Impact factor: 3.216

View more
  11 in total

1.  Evidence for a NOD2-independent susceptibility locus for inflammatory bowel disease on chromosome 16p.

Authors:  Jochen Hampe; Henning Frenzel; Muddassar M Mirza; Peter J P Croucher; Andrew Cuthbert; Silvia Mascheretti; Klaus Huse; Matthias Platzer; Stephen Bridger; Birgit Meyer; Peter Nürnberg; Pieter Stokkers; Michael Krawczak; Christopher G Mathew; Mark Curran; Stefan Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

2.  Association of inflammatory bowel disease with indicators for childhood antigen and infection exposure.

Authors:  Jochen Hampe; Kerstin Heymann; Michael Krawczak; Stefan Schreiber
Journal:  Int J Colorectal Dis       Date:  2003-04-10       Impact factor: 2.571

3.  Linkage of inflammatory bowel disease to human chromosome 6p.

Authors:  J Hampe; S H Shaw; R Saiz; N Leysens; A Lantermann; S Mascheretti; N J Lynch; A J MacPherson; S Bridger; S van Deventer; P Stokkers; P Morin; M M Mirza; A Forbes; J E Lennard-Jones; C G Mathew; M E Curran; S Schreiber
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

4.  Characteristics and therapeutic efficacy of sulfasalazine in patients with mildly and moderately active ulcerative colitis.

Authors:  Qi-Kui Chen; Shi-Zheng Yuan; Zhuo-Fu Wen; Ying-Qiang Zhong; Cu-Jun Li; Hui-Sheng Wu; Can-Rong Mai; Peng-Yan Xie; Yu-Min Lu; Zhong-Lin Yu
Journal:  World J Gastroenterol       Date:  2005-04-28       Impact factor: 5.742

5.  A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort.

Authors:  J Hampe; S Schreiber; S H Shaw; K F Lau; S Bridger; A J Macpherson; L R Cardon; H Sakul; T J Harris; A Buckler; J Hall; P Stokkers; S J van Deventer; P Nürnberg; M M Mirza; J C Lee; J E Lennard-Jones; C G Mathew; M E Curran
Journal:  Am J Hum Genet       Date:  1999-03       Impact factor: 11.025

6.  Ulcerative colitis and Crohn's disease: is Mycobacterium avium subspecies paratuberculosis the common villain?

Authors:  Ellen S Pierce
Journal:  Gut Pathog       Date:  2010-12-17       Impact factor: 4.181

Review 7.  Epidemiological studies of migration and environmental risk factors in the inflammatory bowel diseases.

Authors:  Yanna Ko; Rhys Butcher; Rupert W Leong
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

Review 8.  Progress in searching for susceptibility gene for inflammatory bowel disease by positional cloning.

Authors:  Chang-Qing Zheng; Gang-Zheng Hu; Zhao-Shu Zeng; Lian-Jie Lin; Gin-Ge Gu
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

9.  An epidemiological study of achalasia among the South Asian population of Leicester, 1986-2005.

Authors:  Affifa Farrukh; John DeCaestecker; John F Mayberry
Journal:  Dysphagia       Date:  2007-11-20       Impact factor: 3.438

10.  Stratification by CARD15 variant genotype in a genome-wide search for inflammatory bowel disease susceptibility loci.

Authors:  Sarah H Shaw; Jochen Hampe; Ray White; Christopher G Mathew; Mark E Curran; Stefan Schreiber
Journal:  Hum Genet       Date:  2003-09-13       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.